Abstract

This study aimed to identify any drug-related problems (DRPs) in diabetic patients during Ramadan fasting in Saudi Arabia. The study used a mixed-methods approach consisting of two phases and was conducted in Makkah, Saudi Arabia from December 2017 to March 2018. The first phase of the study involved qualitative semi-structured individual interviews with diabetic patients. A 13-item questionnaire was used in the second phase to further identify DRPs in the wider population. The data was mainly presented as frequencies and percentages. Inferential statistics was performed using Statistical Package for Social Sciences (SPSS) version 21 to compare relevant variables/questions using the chi-square test. Twenty patients (10 male, 10 female) attended face-to-face interviews during the first phase of the study while 95 (40 male, 55 female) completed the questionnaire in the second phase of the study. Two possible risk factors for DRPs were identified from the qualitative data: patient-related factors, including changes in their medicine intake during fasting, and healthcare professionals-related factors, including lack of advice from healthcare professionals regarding fasting. The quantitative results indicated that 52 (54%) of the 95 participants who observed fasting reported to have changed the way they were taking their medicines. Furthermore, 41% of the participants experienced general healthcare problems such as hypoglycemia, hyperglycemia, fatigue, excessive sweating, and gastrointestinal disturbances. Healthcare professionals need to educate patients who are at risk of DRPs by providing structured education and counseling.

Highlights

  • Diabetes is a common chronic disease with a major social, health, and economic impact

  • Almost all participants observed fasting the whole month of Ramadan

  • Participants were allowed to fast by their physicians, with exception of two participants who observed fasting without any medical advice

Read more

Summary

Introduction

Diabetes is a common chronic disease with a major social, health, and economic impact. It is estimated that in 2017, there were 425 million people (20–79 years of age) with diabetes worldwide and it is expected that this number would increase to 629 million by 2045 [1]. Saudi Arabia is ranked second in the Middle East and seventh in the world for the prevalence of diabetes with an estimated. 7 million population suffering from diabetes [2]. Res. Public Health 2019, 16, 499; doi:10.3390/ijerph16030499 www.mdpi.com/journal/ijerph

Objectives
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call